Wegovy And Medical Aid In South Africa

Wegovy is not always affordable out of pocket, particularly long term at maintenance dose. Medical aid cover changes that calculation significantly when it applies. The bad news is that obesity sits in a complicated regulatory space in SA, and cover for weight management medications is patchy.

Here is the honest picture, plus what to ask and how to ask it.

The Big Structural Issue: PMB

The Medical Schemes Act in SA includes a list of conditions called Prescribed Minimum Benefits (PMBs). These are conditions that all registered medical aids must cover, regardless of plan or option. Diabetes is on this list. Hypertension is on it. So is asthma, cancer treatment, HIV, and 22 other chronic conditions on the Chronic Disease List.

Obesity is not on the PMB Chronic Disease List. Despite being recognised internationally as a chronic medical condition with serious health consequences, SA regulation has not yet added it. This means medical aids are not legally required to cover weight management treatments.

The result is that cover for Wegovy specifically for weight management depends entirely on each scheme's voluntary decisions. Some cover, some do not, criteria differ.

What Schemes Are Doing

The landscape is shifting and any specifics here are likely outdated before too long. As a rough orientation:

Discovery Health

Wegovy is covered from medical savings accounts (MSA) or available day-to-day benefits on most plans, subject to scheme rules. This is not 'free' cover but rather using your own allocated medical savings. For people who have MSA available, this is meaningful. For people who have already used their MSA, less so.

Other major schemes

Most other major SA schemes (Bonitas, Momentum, Fedhealth, GEMS, Bestmed) operate similarly. Cover usually comes from MSA or specific day-to-day benefits rather than chronic medication benefit.

Hospital plans

Generally no cover for outpatient weight management medications. These plans cover hospitalisation only.

Specific weight management benefits

A few schemes have specific weight management programmes with criteria around BMI, comorbidities, and engagement with structured support. These can provide additional cover beyond MSA.

How To Find Out What Your Scheme Covers

The reliable approach:

1. Call your scheme directly

Ask specifically:

• "Is Wegovy (semaglutide for weight management) on your formulary?"
• "What option does this cover apply on?"
• "What criteria need to be met?"
• "Is prior authorisation required?"
• "Is there a co-payment or maximum monthly limit?"
• "Does the cover come from medical savings, chronic benefit, or a specific weight management benefit?"

2. Get it in writing

Ask the consultant to email you the answer or send a written reference. Verbal answers from call centres are not always accurate.

3. Check the formulary document

Most schemes publish their full formulary online. Look for 'semaglutide' or 'Wegovy'.

What Helps Get Cover

If your scheme has some cover available but requires criteria:

Documentation of comorbidities

If you have documented type 2 diabetes, hypertension, sleep apnoea, or other comorbidities, ensuring these are properly recorded with the scheme may shift the cover decision.

Specialist motivation

For complex cases, a specialist physician or endocrinologist motivation can sometimes obtain individual cover where the formulary does not include it.

Programme participation

Some schemes will cover Wegovy as part of a structured weight management programme they run or endorse. This often involves regular check ins, weight tracking, and dietetic input.

Appeal

If cover is declined, schemes have formal appeal processes. These work best with strong clinical motivation and documentation.

If Cover Is Not Available

For people paying out of pocket, several practical points:

• Confirm pharmacy pricing before each refill. Different pharmacies have different SEP-aligned pricing and dispensing fees.
• The March 2026 price reductions help significantly, particularly at lower doses.
• Some online dispensing pharmacies offer slightly different pricing than retail.
• Medical expenses may be partially recoverable through tax depending on your situation. Keep receipts.
• Starting and lower doses are cheaper than higher doses. If you respond well at 1 mg or 1.7 mg, ongoing costs are lower than at 2.4 mg.

The Bigger Conversation

Medical aid coverage for weight management medications is likely to evolve in SA over the coming years. Discovery Health has publicly said they are exploring more sustainable funding models. The economic case for treating obesity (which reduces downstream costs of diabetes, cardiovascular disease, joint disease) is becoming clearer. Patent expiry will eventually reduce medication cost.

None of this is immediate. For now, check directly, plan financially, and discuss alternatives if cost makes Wegovy impractical for you.

What Not To Do

Do not turn to compounded semaglutide just because medical aid will not cover Wegovy. The cost savings come with real safety risks. More on this. If regulated treatment is genuinely not affordable, the right alternatives are older regulated medications (Saxenda, Xenical) or non-medication weight management approaches. Both are safer than unregulated copies.